| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.004 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.005 |